Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
014990.KS Stock Summary
Top 10 Correlated ETFs
014990.KS
In the News
014990.KS Financial details
Company Rating
Buy
Market Cap
53.03B
Income
-2.37B
Revenue
126.5B
Book val./share
527.53
Cash/share
101.33
Dividend
-
Dividend %
-
Employees
174
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-8.24
Forward P/E
-
PEG
1.1
P/S
0.47
P/B
1.77
P/C
6.73
P/FCF
10.37
Quick Ratio
-
Current Ratio
0.7
Debt / Equity
1.1
LT Debt / Equity
0.1
-
-
EPS (TTM)
-36.43
EPS next Y
-
EPS next Q
-
EPS this Y
-84.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-24.68%
Revenue last 5Y
-8.98%
Revenue Q/Q
23.73%
EPS Q/Q
-340.57%
-
-
-
-
SMA20
-4.77%
SMA50
-7.66%
SMA100
-21.2%
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-21%
ROC
-0.06%
Gross Margin
54%
Oper. Margin
-2%
Profit Margin
-6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
692.0-1430.0
52W High
-52.31%
52W Low
-1.45%
RSI
30
Rel Volume
0.84
Avg Volume
95.53K
Volume
79.9K
Perf Week
-5.28%
Perf Month
-8.09%
Perf Quarter
-26.67%
Perf Half Y
-22.41%
-
-
-
-
Beta
1.689
-
-
Volatility
15.8%, 18.64%
Prev Close
0.44%
Price
682
Change
1.19%
014990.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.44K | 2.59K | 2.47K | 1.91K | 1.73K | |
Net income per share | -93.39 | -367.75 | -333.43 | -143.89 | -22.64 | |
Operating cash flow per share | 174.93 | -11 | -70.17 | 48.81 | 74.28 | |
Free cash flow per share | 102.92 | -84.86 | -137.27 | 11.93 | 51.9 | |
Cash per share | 161.16 | 203.44 | 278.78 | 125.72 | 104.19 | |
Book value per share | 1.06K | 698.98 | 629.05 | 536.62 | 542.42 | |
Tangible book value per share | 1.05K | 685.76 | 603.82 | 513.73 | 531.57 | |
Share holders equity per share | 1.06K | 698.98 | 629.05 | 536.62 | 542.42 | |
Interest debt per share | 839.55 | 1.06K | 916.71 | 709.81 | 642.14 | |
Market cap | 139.66B | 88.1B | 79.02B | 100.41B | 58.37B | |
Enterprise value | 179.34B | 137.69B | 116.32B | 140.82B | 95.89B | |
P/E ratio | -25.38 | -4.07 | -3.93 | -9.87 | -35.28 | |
Price to sales ratio | 0.69 | 0.58 | 0.53 | 0.74 | 0.46 | |
POCF ratio | 13.55 | -135.92 | -18.67 | 29.09 | 10.76 | |
PFCF ratio | 23.03 | -17.62 | -9.54 | 119.01 | 15.4 | |
P/B Ratio | 2.23 | 2.14 | 2.08 | 2.65 | 1.47 | |
PTB ratio | 2.23 | 2.14 | 2.08 | 2.65 | 1.47 | |
EV to sales | 0.89 | 0.9 | 0.78 | 1.04 | 0.76 | |
Enterprise value over EBITDA | 20.9 | -17.33 | -18.89 | 72.88 | 15.27 | |
EV to operating cash flow | 17.4 | -212.43 | -27.48 | 40.8 | 17.67 | |
EV to free cash flow | 29.57 | -27.53 | -14.05 | 166.9 | 25.29 | |
Earnings yield | -0.04 | -0.25 | -0.25 | -0.1 | -0.03 | |
Free cash flow yield | 0.04 | -0.06 | -0.1 | 0.01 | 0.06 | |
Debt to equity | 0.76 | 1.45 | 1.39 | 1.26 | 1.1 | |
Debt to assets | 0.32 | 0.43 | 0.42 | 0.4 | 0.38 | |
Net debt to EBITDA | 4.62 | -6.24 | -6.06 | 20.91 | 5.98 | |
Current ratio | 1.24 | 0.95 | 1.01 | 0.75 | 0.75 | |
Interest coverage | -0.46 | -8.25 | -9.32 | -3.08 | -0.79 | |
Income quality | -3.18 | 0.03 | 0.21 | -0.34 | -3.28 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.41 | 6.72 | 0.96 | -0.76 | -0.3 | |
Capex to revenue | -0.02 | -0.03 | -0.03 | -0.02 | -0.01 | |
Capex to depreciation | -0.44 | -0.39 | -0.36 | -0.27 | -0.18 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.49K | 2.4K | 2.17K | 1.32K | 525.7 | |
ROIC | -0.01 | -0.17 | -0.22 | -0.08 | -0.03 | |
Return on tangible assets | -0.04 | -0.16 | -0.16 | -0.09 | -0.01 | |
Graham Net | -597.43 | -842.03 | -645.42 | -653.18 | -610.01 | |
Working capital | 16.31B | -3.88B | 420.24M | -17.99B | -16.15B | |
Tangible asset value | 61.85B | 40.41B | 36.42B | 36.33B | 38.83B | |
Net current asset value | -3.2B | -20.46B | -15.11B | -26.99B | -27.45B | |
Invested capital | 0.76 | 1.45 | 1.39 | 1.26 | 1.1 | |
Average receivables | 20.41B | 16.72B | 14.46B | 15.29B | 14.45B | |
Average payables | 22.3B | 18.74B | 18.42B | 16.76B | 14.95B | |
Average inventory | 58.98B | 52.81B | 45.76B | 35.38B | 28.84B | |
Days sales outstanding | 36.17 | 31.96 | 38.14 | 40.6 | 39.96 | |
Days payables outstanding | 67.31 | 84.35 | 83.02 | 83.71 | 83.17 | |
Days of inventory on hand | 197.43 | 228.3 | 186.32 | 164.09 | 157.53 | |
Receivables turnover | 10.09 | 11.42 | 9.57 | 8.99 | 9.13 | |
Payables turnover | 5.42 | 4.33 | 4.4 | 4.36 | 4.39 | |
Inventory turnover | 1.85 | 1.6 | 1.96 | 2.22 | 2.32 | |
ROE | -0.09 | -0.53 | -0.53 | -0.27 | -0.04 | |
Capex per share | -72.01 | -73.86 | -67.09 | -36.88 | -22.38 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 513.75 | 419.59 | 487.01 | 369.89 | 457.67 | |
Net income per share | 14.49 | -77.78 | -5.18 | -33.1 | 79.63 | |
Operating cash flow per share | 60.29 | 19.63 | 15.37 | 35.59 | 35.92 | |
Free cash flow per share | 45.19 | 16.89 | 5.52 | 34.25 | 27.41 | |
Cash per share | 125.72 | 107.09 | 74.13 | 60.77 | 101.33 | |
Book value per share | 536.62 | 467.48 | 514.06 | 455.51 | 527.53 | |
Tangible book value per share | 513.73 | 445.74 | 493.61 | 443.96 | 516.98 | |
Share holders equity per share | 536.62 | 467.48 | 514.06 | 455.51 | 527.53 | |
Interest debt per share | 684.28 | 716.5 | 630.76 | 567.47 | 590.75 | |
Market cap | 100.41B | 72.05B | 80.09B | 70.3B | 60.01B | |
Enterprise value | 140.82B | 116.23B | 120.21B | 109.04B | 97.54B | |
P/E ratio | 24.5 | -3.28 | -54.3 | -7.07 | 2.51 | |
Price to sales ratio | 2.76 | 2.43 | 2.31 | 2.53 | 1.75 | |
POCF ratio | 23.55 | 51.9 | 73.19 | 26.3 | 22.25 | |
PFCF ratio | 31.42 | 60.33 | 203.68 | 27.33 | 29.15 | |
P/B Ratio | 2.65 | 2.18 | 2.19 | 2.05 | 1.51 | |
PTB ratio | 2.65 | 2.18 | 2.19 | 2.05 | 1.51 | |
EV to sales | 3.88 | 3.92 | 3.47 | 3.92 | 2.84 | |
Enterprise value over EBITDA | 26.71 | 8.26 | 6.08 | 7.48 | 19.13 | |
EV to operating cash flow | 33.03 | 83.72 | 109.85 | 40.79 | 36.15 | |
EV to free cash flow | 44.07 | 97.31 | 305.69 | 42.39 | 47.38 | |
Earnings yield | 0.01 | -0.08 | 0 | -0.04 | 0.1 | |
Free cash flow yield | 0.03 | 0.02 | 0 | 0.04 | 0.03 | |
Debt to equity | 1.26 | 1.51 | 1.2 | 1.22 | 1.1 | |
Debt to assets | 0.4 | 0.44 | 0.41 | 0.39 | 0.38 | |
Net debt to EBITDA | 7.66 | 3.14 | 2.03 | 2.66 | 7.36 | |
Current ratio | 0.75 | 0.68 | 0.71 | 0.7 | 0.75 | |
Interest coverage | 4.01 | -5.65 | 0.33 | -2.24 | 3.32 | |
Income quality | 4.16 | -0.29 | -2.97 | -1.08 | 0.45 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.61 | 0.56 | 0.59 | 0.01 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.25 | -0.14 | -0.64 | -0.04 | -0.24 | |
Capex to revenue | -0.03 | -0.01 | -0.02 | 0 | -0.02 | |
Capex to depreciation | -0.46 | -0.09 | -0.31 | -0.04 | -0.3 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 418.3 | 904.52 | 244.77 | 582.41 | 972.22 | |
ROIC | 0.01 | -0.05 | 0 | -0.02 | 0.03 | |
Return on tangible assets | 0.01 | -0.05 | 0 | -0.02 | 0.05 | |
Graham Net | -653.18 | -724.83 | -627.44 | -624.38 | -593.27 | |
Working capital | -17.99B | -22.68B | -17.63B | -19.01B | -16.15B | |
Tangible asset value | 36.33B | 31.52B | 35.14B | 33.35B | 38.83B | |
Net current asset value | -26.99B | -34.26B | -28.76B | -29.94B | -27.45B | |
Invested capital | 1.26 | 1.51 | 1.2 | 1.22 | 1.1 | |
Average receivables | 13.71B | 13.22B | 10.9B | 10.48B | 12.2B | |
Average payables | 17.01B | 14.87B | 12.74B | 13.74B | 15.08B | |
Average inventory | 32.98B | 29.59B | 27.46B | 27.63B | 27.73B | |
Days sales outstanding | 37.3 | 34.52 | 27.06 | 34.15 | 36.26 | |
Days payables outstanding | 90.7 | 80.77 | 69.46 | 109.06 | 93.55 | |
Days of inventory on hand | 177.8 | 163.34 | 160.86 | 195.26 | 177.18 | |
Receivables turnover | 2.41 | 2.61 | 3.33 | 2.64 | 2.48 | |
Payables turnover | 0.99 | 1.11 | 1.3 | 0.83 | 0.96 | |
Inventory turnover | 0.51 | 0.55 | 0.56 | 0.46 | 0.51 | |
ROE | 0.03 | -0.17 | -0.01 | -0.07 | 0.15 | |
Capex per share | -15.1 | -2.74 | -9.85 | -1.34 | -8.51 |
014990.KS Frequently Asked Questions
What is In the F Co.,Ltd. stock symbol ?
In the F Co.,Ltd. is a KR stock and trading under the symbol 014990.KS
What is In the F Co.,Ltd. stock quote today ?
In the F Co.,Ltd. stock price is $682 today.
Is In the F Co.,Ltd. stock public?
Yes, In the F Co.,Ltd. is a publicly traded company.